Nando Mertineit

Nando Mertineit

Auto-generated profile, based on publicly available information

Nando Mertineit

Institut für Medizinische Radiologie (IMR) Bürgerspital Solothurn, Solothurn, Switzerland

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2017 in Diagnostic Pathology
Verified
Journal Article
Open access
PDF file
MTMafalda Trippel
Mafalda Trippel
SISara Imboden
Sara Imboden
APAndrea Papadia
Andrea Papadia
MMMichael Mueller
Michael Mueller
NMNando Mertineit
Nando Mertineit
TRTilman T. Rau
Tilman T. Rau
Intestinal differentiation of primary mucinous adenocarcinoma of the uterine corpus is exceedingly rare in comparison to the approximately 25% rate in endocervical and ovarian mucinous carcinoma. Additionally, little is known about the related genetic and epigenetic alterations, even though large-scale molecular characterisation of the different types of endometrial cancer took place in the TCGA project along the entities defined by the recent WHO classification. We present a 62-year-old patient harbouring a primary mucinous carcinoma of the uterine corpus with a morphological resemblance to mucinous colorectal adenocarcinoma. The intestinal differentiation was substantiated by CDX2 and CK20 positivity in the absence of PAX8, p16, WT1, p53, ER, PgR, AFP, SALL4 and Glypican3. A high MSI status with MLH1 hypermethylation was revealed by molecular testing. Intestinal differentiation of mucinous adenocarcinoma of the endometrium is a unique observation. Besides morphology, it obviously can share molecular features of sporadic MSI colorectal cancers. It can be speculated that either CDX2 positive morula formation or intestinal metaplasia of the endometrium as rare conditions might be the origin of carcinogenesis for this type II endometrial cancer. Both conditions were not detectable in this case. Of note, categorising endometrial cancers in genetic subgroups like MSI high cancers alone might lead to the integration of likewise morphologically different tumours like the case presented here with intestinal differentiation. Hence, careful genotype-phenotype correlations are warranted for studies of mucinous adenocarcinoma of the endometrium.

24 February 2024 in Swiss Journal of Radiology and Nuclear Medicine
Verified
Journal Article
Open access
PDF file
SGStefanie Nicole Garni
Stefanie Nicole Garni
NMNando Mertineit
Nando Mertineit
GNGerd Nöldge
Gerd Nöldge
KDKeivan Daneshvar
Keivan Daneshvar
FMFrank Mosler
Frank Mosler
Artificial intelligence (AI) is increasingly employed in radiation protection, encompassing both medical devices and software. These technologies are integrated with AI throughout their manufacturing and application processes. This article underscores the imperative for comprehensive regulation in the utilization of AI. Decisions regarding AI application should not solely rest with manufacturers, medical professionals, or patients. Instead, an overarching "neutral" authority must be engaged to regulate, review, and enforce adherence to established protocols. The authors contend that relying on "self-regulation" within the free market, absent clear guidelines, proves to be inadequately effective and leads to patient's radiation protection safety issues.

1 June 2023 in Swiss Journal of Radiology and Nuclear Medicine
Verified
Journal Article
Open access
PDF file
FMFrank Mosler
Frank Mosler
NMNando Mertineit
Nando Mertineit
GNGerd Nöldge
Gerd Nöldge
Characteristic of the osteoid osteoma is the so-called nidus enclosed in the tumor and produces a typical picture on X-ray. Since most physicians have little experience with the clinical picture of osteoid osteoma, this is an important reason for the often-long anamnesis time for osteoid osteoma (OO). The period of formation of OO includes the phase of strongest bone growth in childhood and adolescence. The most characteristic clinical symptom is nocturnal attacks of pain around the tumor, which occur independently of preceding physical activity and respond strikingly well to non-steroidal anti-inflammatory drugs (aspirin test). OO most frequently affects the long tubular bones of the lower extremities. Fifty percent of OO are found in the femur and tibia preferentially occurring in the corticalis of metaphysis and diaphysis. This is followed by the long tubular bones of the upper extremity and the short tubular bones. However, any other bone can also be affected. Differentially, osteoblastoma or osteosarcoma must be considered first and foremost. Most widely accepted therapy options are open surgery with en-bloc resection of the tumor, excochleation,minimally invasive percutaneous CT-guided radio or laser ablation. A conservative management by pharmaceutical pain therapy should be reserved for cases in which surgery must be refused either because of the precarious position of the nidus or because the patient's general condition does not permit it, or the patient does not consent to surgical interventions.

30 March 2024 in Swiss Journal of Radiology and Nuclear Medicine
Verified
Journal Article
Open access
PDF file
NMNando Mertineit
Nando Mertineit
CTCarlos Buitrago Tellez
Carlos Buitrago Tellez
PKPascal Kissling
Pascal Kissling
FMFrank Mosler
Frank Mosler
JHJohannes Heverhagen
Johannes Heverhagen
GNGerd Nöldge
Gerd Nöldge
The therapy of pelvic aneurysms is minimally invasive through interventional radiology using various devices and embolic agents: 1. By using a covered stent/prosthesis to maintain antegrade flow when a landing zone, i.e., a vascular segment angiographically present into which the stent can be placed to bridge the neck of the aneurysm, thereby interrupting aneurysm perfusion. 2. Through complete embolization of the aneurysm using embolic agents/coils. 3. As performed in our case, by covering the aneurysm (Img 14 A-C) with a covered stent /prosthesis, following prior embolization of the branching vessels using macroembolic agents. In cases where there is insufficient occlusion of the aneurysm with residual perfusion, secondary em- bolization becomes considerably more complex due to the occlusion of the anatomically antegrade access and the altered hemodynamics around the aneurysm causing retrograde collateralization. Through detailed analysis of CT angiography, even in static CT, retrograde circulation could be iden- tified, allowing for a minimally invasive secondary approach to the aneurysm without the need for general anesthesia and/or surgery. By completely eliminating the aneurysm, the risk of rupture in the elderly patient was minimally invasively eliminated. The treatment of this patient exemplifies the possibilities that embolization with a wide array of embolic agents and catheters offers in a hemo- dynamically very complex situation.

30 March 2024 in Swiss Journal of Radiology and Nuclear Medicine
Verified
Journal Article
Open access
PDF file
KDKeivan Daneshvar
Keivan Daneshvar
WBWolfram Bosbach
Wolfram Bosbach
NMNando Mertineit
Nando Mertineit
GNGerd Nöldge
Gerd Nöldge
FMFrank Mosler
Frank Mosler
The second most common hematologic malignancy is the clonal proliferation of neoplastic plasma cells within the bone marrow. There is the presence of monoclonal immunoglobulins in the serum and/or urine. This results in anemia, myelosuppression, bone destruction, and clinical consequences of paraproteinemia on kidney function and other organ systems. The disease manifests through the acronym CRAB (hypercalcemia, renal impairment, anemia, and bone lesions). Less frequent manifestations of multiple myeloma are of extramedullary localizations. Myeloma cells can become independent of the bone marrow microenvironment, circulate freely in the blood, and infiltrate organs. This results in a high-risk state characterized by increased proliferation, evasion of apoptosis, and treatment resistance. It can affect any area of tissue. Most commonly it involves the pleura, lymph nodes, chest wall, liver, skin/soft tissue, lungs, CNS, genitourinary system, breast and pancreas. In patients with confirmed multiple myeloma, the diagnosis of extramedullary involvement is typically established by the presence of pathological soft tissue masses using radiological methods such as computed tomography (CT) scan, positron emission tomography/CT (PET/CT), magnetic resonance imaging (MRI), or ultrasound, along with biopsy or physical examination. The molecular mechanisms underlying the development of extramedullary multiple myeloma (EMM) have not been fully defined. Various cytogenetic abnormalities are observed, and some studies have generated genomic sequencing profiles that distinguish EMM from classic multiple myeloma. While plasma cell leukemia (PCL) and central nervous system (CNS) EMM indicate a poor prognosis, outcomes for other manifestations can be highly heterogeneous. Sensitive imaging modalities including PET/CT and MRI (Fig.1) are integral components of diagnosis and response assessment. Patients with extramedullary multiple myeloma (EMM) have a clear survival disadvantage.

31 January 2024 in Swiss Journal of Radiology and Nuclear Medicine
Verified
Journal Article
Open access
PDF file
KDKeivan Daneshvar
Keivan Daneshvar
JHJohannes Huber
Johannes Huber
WBWolfram Bosbach
Wolfram Bosbach
NMNando Mertineit
Nando Mertineit
GNGerd Nöldge
Gerd Nöldge
Purpose: To compare the efficacy of computed tomography (CT) and magnetic resonance imaging (MRI) in evaluating cystic renal masses using the Bosniak classification system. Materials and Methods: Between January 2010 and December 2020, a total of 844 patients with suspected renal masses underwent total or partial nephrectomy at the Department of Urology, Heidelberg University Clinic. Among them, 123 patients presented with cystic renal masses. Out of this cohort, 15 patients underwent preoperative examinations using both MRI and CT within a 6-week timeframe. These examinations were retrospectively analyzed by two radiologists employing the Bosniak classification system. Each lesion was assessed based on CT images for lesion localization, volume, number, and thickness of septa/wall, calcification, presence of enhancing soft-tissue components, and lesion density. Pathologic correlation was available for all lesions. Results: Out of the 844 patients, 15 underwent both CT and MR imaging examinations (male-to-female ratio: 2.75, age range: 43-75 years; mean age: 60.5 years). Based on CT images, there were one category I, one category II, three category IIF, three category III, and seven category IV lesions. Findings based on CT and MR images were concordant in eleven (73.3%) renal lesions, while in 4 (26.7%) masses, differences were observed. In three (20%) cases, MR imaging revealed more septa/wall than CT, resulting in an upgrade of the classification at MR imaging. In one (6.7%) lesion, MR imaging showed no wall and/or septa thickness compared with CT, leading to a classification downgrade. MR imaging results led to a cyst classification upgrade in three masses (from category II to III, n=1; IIF to III, n=2) and downgrade in one lesion (from category IIF to II). Pathologically, 11 lesions (73.3%) were malignant (9 Cystic Clear cell carcinoma and 2 papillary renal cell carcinoma), while 4 lesions were renal cysts without malignancy. Conclusion: The majority of findings from both CT and MR imaging were similar in suspected cystic renal masses. MR imaging demonstrated additional septa/wall or septa/wall thickening, potentially upgrading lesions from borderline category IIF to III compared to CT. This distinction may contribute to improved case management.